​

MiNK Therapeutics Ownership | Who Owns MiNK Therapeutics?

OverviewForecastFinancialsChartTranscripts

MiNK Therapeutics Ownership Summary

MiNK Therapeutics is owned by 65.56% insiders, and 34.43% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.37% of its assets in MiNK Therapeutics shares.

INKT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMiNK Therapeutics-65.56%34.43%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251-144-99.14%-205.71%1---100.00%
Mar 31, 20251-95.65%16,667-97.94%-1.00%--100.00%1-83.33%
Dec 31, 202423-11.54%809,544-4.38%244.65%6-33.33%6-14.29%
Sep 30, 202426-13.33%846,639-5.78%231.83%9-7-30.00%
Jun 30, 202430-9.09%898,529-4.07%234.90%928.57%10-16.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv14.82K0.37%-324.00
Vanguard Institutional Extnd Mkt Idx Tr10.07K0.25%1.48K
Fidelity Extended Market Index5.53K0.14%-
Fidelity Nasdaq Composite Index1.90K0.05%-
Fidelity Series Total Market Index1.64K0.04%-
Spartan Extended Market Index Pool F1.43K0.04%-
Spartan Extended Market Index Pool E1.38K0.03%1.26K
iShares Micro-Cap ETF999.000.03%-
BlackRock Extended Equity Market K8.48K0.02%-4.00
Extended Equity Market Fund K822.000.02%-16.00

Recent Insider Transactions

DateNameRoleActivityValue
Oct 16, 2023AGENUS INC-Buy$471.56
Oct 12, 2023AGENUS INC-Buy$3.49K
Oct 13, 2023AGENUS INC-Buy$21.31K
Oct 04, 2023AGENUS INC-Buy$16.38K
Aug 29, 2023AGENUS INC-Buy$45.02K

Insider Transactions Trends

DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q3--

INKT Ownership FAQ

Who Owns MiNK Therapeutics?

MiNK Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 65.56% insiders and 34.44% retail investors. The average institutional ownership in MiNK Therapeutics's industry, Biotech Stocks , is 306.59%, which MiNK Therapeutics falls below.

Does Blackrock own MiNK Therapeutics?

BlackRock is not among the top 10 institutional shareholders of MiNK Therapeutics.

Who is the top mutual fund holder of MiNK Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of MiNK Therapeutics shares, with 0.37% of its total shares outstanding invested in 14.82K MiNK Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools